# Fidelity Biosciences: portfolio, investments and team

> Fidelity Biosciences is an investment firm. 46 investments on record, latest Nov 2014. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/fidelity-biosciences (Millionrounds; every figure on the page links to its filing or article)

[Investor](https://millionrounds.com/investors)

# Fidelity Biosciences

Last cheque observed Nov 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet Investment firm

Series A Series B Series C

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 46 on record

Since the last cheque **4359** days **00** hrs **00** min **00** sec

Median round **$21M** Rounds led **0 of 46** Exits **6 from the portfolio** Mostly in **United States, 90%**

Pitch Fidelity Biosciences

## Fidelity Biosciences highlights

- 01 46 rounds on record
- 02 Mostly Series A and Series B: 61% of its rounds
- 03 6 exits from the portfolio

## What they do

- **Type:** Investment firm (from a list, unverified)
- **Cheque size:** Not stated
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **46 appearances**

- **2014** 9 rounds
- **Nov** **[Novaerus](https://millionrounds.com/company/novaerus)** Venture · US **$10M** With 2 others
- **Oct** **[UNUM Therapeutics](https://millionrounds.com/company/unum-therapeutics)** Series A · US **$12M** With 3 others
- **Oct** **[Avidity NanoMedicines](https://millionrounds.com/company/avidity-nanomedicines)** Series B · US **$6.0M** With 4 others
- **Oct** **[Aclaris Therapeutics](https://millionrounds.com/company/aclaris-therapeutics)** Series B · US **$21M** With 3 others
- **Sept** **[Adaptimmune](https://millionrounds.com/company/adaptimmune)** Series A · GB **$104M** With 12 others
- **Jun** **[Dimension Therapeutics](https://millionrounds.com/company/dimension-therapeutics)** Series A · US **$30M** With 2 others
- **May** **[Coherus Biosciences](https://millionrounds.com/company/coherus-biosciences)** Series C · US **$55M** With 9 others
- **Apr** **[Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)** Series A · US **$15M** With 2 others
- **Jan** **[Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines)** Series B · US **$25M** With 5 others
- **2013** 8 rounds
- **Dec** **[ViewRay](https://millionrounds.com/company/viewray)** Venture · US **$30M** With 5 others
- **Nov** **[Pulmocide](https://millionrounds.com/company/pulmocide)** Series A · GB · finsmes.com **$28M** With 4 others
- **Oct** **[Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)** Series A · US · boston.citybizlist.com **$5.0M** With 1 other
- **Sept** **[Acacia Pharma](https://millionrounds.com/company/acacia-pharma)** Series B · GB · finsmes.com **$24M** With 2 others
- **May** **[ViewRay](https://millionrounds.com/company/viewray)** Series D · US · pehub.com **$15M** With 5 others
- **Apr** **[Iora Health](https://millionrounds.com/company/iora-health)** Series B · US · finsmes.com **$14M** With 4 others
- **Mar** **[US HealthVest](https://millionrounds.com/company/us-healthvest)** Series A · US · pehub.com **$36M** With 5 others
- **Jan** **[Kyruus](https://millionrounds.com/company/kyruus)** Series B · US · kyruus.com **$11M** With 5 others
- **2012** 8 rounds
- **Dec** **[Ultragenyx Pharmaceutical](https://millionrounds.com/company/ultragenyx-pharmaceutical)** Growth · US · globenewswire.com **$75M** With 6 others
- **Nov** **[Innovent Biologics](https://millionrounds.com/company/innovent-biologics)** Series B · CN · fiercepharmamanufacturing.com **$25M** With 4 others
- **Oct** **[Aclaris Therapeutics](https://millionrounds.com/company/aclaris-therapeutics)** Series A · US · finsmes.com **$21M** With 3 others
- **Aug** **[Procured Health](https://millionrounds.com/company/procured-health)** Seed · US · techcrunch.com **$1.1M** With 6 others
- **Jul** **[Mersana Therapeutics](https://millionrounds.com/company/mersana-therapeutics)** Series A · US · finsmes.com **$27M** With 4 others
- **Jul** **[Ultragenyx Pharmaceutical](https://millionrounds.com/company/ultragenyx-pharmaceutical)** Series A · US · bizjournals.com **$15M** With 1 other
- **Apr** **[Liazon](https://millionrounds.com/company/liazon)** Series D · US · liazon.com **$18M** With 4 others
- **Mar** **[ViewRay](https://millionrounds.com/company/viewray)** Series C · US · finsmes.com **$45M** With 5 others
- **2011** 6 rounds
- **Oct** **[Imagen Biotech](https://millionrounds.com/company/imagen-biotech)** Series A · US · businesswire.com **$40M** With 4 others
- **Sept** **[ViewRay](https://millionrounds.com/company/viewray)** Venture · US · wraltechwire.com **$10M** With 5 others
- **Aug** **[Fluidnet](https://millionrounds.com/company/fluidnet)** Series C · US · fluidnet.net **$25M** With 5 others
- **Jun** **[Ultragenyx Pharmaceutical](https://millionrounds.com/company/ultragenyx-pharmaceutical)** Series A · US · finsmes.com **$45M** With 4 others
- **Apr** **[Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines)** Series A · US · blueprintmedicines.com **$40M** With 2 others
- **Jan** **[NextWave Pharmaceuticals](https://millionrounds.com/company/nextwave-pharmaceuticals)** Series C · US · finsmes.com **$45M** With 7 others
- **2010** 5 rounds
- **Oct** **[Accuri Cytometers](https://millionrounds.com/company/accuri-cytometers)** Series E · US · onbiovc.com **$6.0M** With 5 others
- **Aug** **[ViewRay](https://millionrounds.com/company/viewray)** Series C · US · viewray.com **$20M** With 5 others
- **Jun** **[Vicept Therapeutics](https://millionrounds.com/company/vicept-therapeutics)** Series A · US · vicepttx.com **$16M** With 4 others
- **Jun** **[Foldrx Pharmaceuticals](https://millionrounds.com/company/foldrx-pharmaceuticals)** Venture · US · fiercebiotech.com **$29M** With 7 others
- **Jun** **[Tetraphase Pharmaceuticals](https://millionrounds.com/company/tetraphase-pharmaceuticals)** Series C · US · fiercebiotech.com **$45M** With 7 others
- **2009** 1 round
- **Aug** **[Accuri Cytometers](https://millionrounds.com/company/accuri-cytometers)** Series D · US · onbiovc.com **$4.0M** With 6 others
- **2008** 4 rounds
- **Aug** **[Proteostasis Therapeutics](https://millionrounds.com/company/proteostasis-therapeutics)** Series A · US · sec.gov **$71M** With 5 others
- **Jul** **[Accuri Cytometers](https://millionrounds.com/company/accuri-cytometers)** Series C · US · sec.gov **$13M** With 3 others
- **Jan** **[ViewRay](https://millionrounds.com/company/viewray)** Series B · US **$25M** With 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## Exits from the portfolio

Companies it backed that were later bought or listed **6 in all**

**[NextWave Pharmaceuticals](https://millionrounds.com/company/nextwave-pharmaceuticals)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Oct 2012

**[Vicept Therapeutics](https://millionrounds.com/company/vicept-therapeutics)** Bought by [Allergan](https://millionrounds.com/fund/allergan) **$275M** Jul 2011

**[NovaMed Pharmaceuticals](https://millionrounds.com/company/novamed-pharmaceuticals)** Bought by [SciClone Pharmaceuticals](https://millionrounds.com/fund/sciclone-pharmaceuticals) **$105M** Apr 2011

**[Accuri Cytometers](https://millionrounds.com/company/accuri-cytometers)** Bought by (Becton, Dickinson and Company) **Undisclosed** Mar 2011

**[Microbia](https://millionrounds.com/company/microbia)** Bought by DSM **Undisclosed** Sept 2010

**[Foldrx Pharmaceuticals](https://millionrounds.com/company/foldrx-pharmaceuticals)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Sept 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series A Series B Series C

Median round joined **$21M** the round, not its cheque

Led 0 of 46 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Nov 2014
- **Exits:** 6 from the portfolio

Rounds by stage said on their site

- Series A *18*
- Series B *9*
- Series C *7*
- Venture *5*
- Series D *3*
- Series E *2*

Cheques by year Led Joined

2005 2014

Often in the room with

- [F-Prime Capital](https://millionrounds.com/fund/f-prime) 38
- [Aisling Capital](https://millionrounds.com/fund/aisling-capital) 8
- [OrbiMed](https://millionrounds.com/fund/orbimed) 8
- [Kearny Venture Partners](https://millionrounds.com/fund/kearny-venture-partners) 7
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 5
- [Sofinnova Investments](https://millionrounds.com/fund/sofinnova-investments) 5

**Pitching Fidelity Biosciences?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Fidelity Biosciences. A count of rooms they were both in, not a relationship either has claimed.

[**F-Prime Capital** VC firm **38** rounds together](https://millionrounds.com/fund/f-prime)[**Aisling Capital** Private equity **8** rounds together](https://millionrounds.com/fund/aisling-capital)[**OrbiMed** Private equity **8** rounds together](https://millionrounds.com/fund/orbimed)[**Kearny Venture Partners** VC firm **7** rounds together](https://millionrounds.com/fund/kearny-venture-partners)[**New Enterprise Associates** VC firm **5** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Sofinnova Investments** VC firm **5** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**Polaris Partners** VC firm **4** rounds together](https://millionrounds.com/fund/polaris-partners)[**Siemens** Corporate VC **4** rounds together](https://millionrounds.com/fund/siemens)[**Vivo Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/vivo-ventures)[**Arboretum Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/arboretum-ventures)[**Carl Byers** Angel **3** rounds together](https://millionrounds.com/fund/carl-byers)[**Flagship Pioneering, LLC** VC firm **3** rounds together](https://millionrounds.com/fund/flagship-pioneering-llc)

## Quick answers about Fidelity Biosciences

### What does Fidelity Biosciences invest in?

Fidelity Biosciences invests most often at Series A and Series B (61% of the rounds on record).

### How active is Fidelity Biosciences?

46 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2014.

### How big are Fidelity Biosciences's cheques?

The median round it joins is $21M.

### Does Fidelity Biosciences lead rounds?

Rarely, if at all: none of its 46 investments on record names it as the lead.

### Where does Fidelity Biosciences invest?

Most of the companies it backs are in the United States (90%) and the United Kingdom (8%).

### Is Fidelity Biosciences investing now?

No investments in the last 12 months; the latest was in Nov 2014.

### Who does Fidelity Biosciences invest alongside?

Most often F-Prime Capital (38 rounds together), Aisling Capital (8 rounds together) and OrbiMed (8 rounds together).

### What kind of investor is Fidelity Biosciences?

Fidelity Biosciences is an investment firm.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=fidelity-biosciences) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=fidelity-biosciences)